In-silico studies of Neurocognitive and Neuropharmacological effect of Bacopa monnieri (L.)
Abstract
Different Indian therapeutic plants have picked up consideration for their restorative properties against neurodevelopmental disorders lately. Bacopa monnieri (B. monnieri), being one of them, finds its utilization significantly in the treatment of cognition and learning. Despite the fact that it possesses such great capacity to treat neurological issues, how precisely it confers its influence is muddled. This study makes a stride towards knowing which phytochemical is significantly associated with granting B. monnieri with therapeutic properties. The docking investigation and the molecular simulation studies proposes that there is no single phytochemical included that imparts B. monnieri a significant medicinal effect. It is really the blend of dominant part of natural phytochemicals present in B. monnieri that bestows the anti-neurological activity to B. monnieri. The ADME studies shows the convergence of properties of phytochemicals of B. monnieri with that of commercially available drugs which suggests that phytochemicals of B. monnieri can used as a potential drug source to treat neurodegenerative and neurodevelopmental disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico analysis of Bacopa monnieri (L.) Wettst. compounds for drug development against Neurodegenerative Disorders
S. Sangeet, A. Khan, … P. K. Hui·bioRxiv·Mar 30, 2022
- Small molecules from Bacopa monneiri as potent inhibitors against Neurodegenerative disorders
Satyam Sangeet, Arshad Khan·bioRxiv·Mar 31, 2022
- Isolation and characterization of Bacopa monnieri (L.) Wettst-derived nanovesicles with anti-neuroblastoma potential
Ekkaphot Khongkla, Panitch Boonsnongcheep, … Banthit Chetsawang·bioRxiv·Jan 21, 2026
- Exploring the Therapeutic Potential of Cannabis Constituents in Parkinson's Disease: Insights from Molecular Docking Studies
Moawaz Aziz, Hafsa Rehman, … Muhammad Arsalan Ali Sajid·bioRxiv·Nov 11, 2023
- Preclinical efficacy of bacosides-lauric acid nano-herbal formulation incomparison to rivastigmine for treatment of Alzheimer's disease
- Dizocilpine derivatives with neuroprotective effect lacking the psychomimetic side effects
Jan Konecny, Anna Misiachna, … Martin Hořák·bioRxiv·Jun 17, 2024